Status:

COMPLETED

Nucleoplasty for Contained Herniated Lumbar Discs

Lead Sponsor:

Rijnstate Hospital

Collaborating Sponsors:

Maastricht University

ArthroCare Corporation

Conditions:

Herniated Disc

Eligibility:

All Genders

18-60 years

Phase:

PHASE3

Brief Summary

This is a prospective randomised double blind comparison trial. Fifty patients will be included, 25 in the nucleoplasty treatment group, 25 in the control group. The nucleoplasty group will undergo th...

Detailed Description

This study will include patients with a contained lumbar hernia of at least 6 weeks existence in whom leg pain is the predominant complaint. Standard treatment for these patients is conservative, as a...

Eligibility Criteria

Inclusion

  • Mono radicular leg pain for at least 6 weeks as a result from a lumbar contained herniated disc. Leg pain must be of greater impact than concomitant back-pain
  • Failing conservative treatment; analgesics and/or physical therapy. Failing means persisting pain leading to problems with daily activities.
  • Magnetic resonance imaging (MRI): must be performed \< 6 weeks before start treatment. On MRI signs of contained herniated disc, maximum 33% obliteration of the spinal channel. No signs of other significant spine pathology (see exclusion criteria).
  • Neurological investigation by neurologist. Symptoms should be clinically related to the disc herniation level.
  • Age \>18 and \< 60 years
  • Mean leg pain on visual analogue scale (VAS) \>50 mm (0 -100)

Exclusion

  • Herniated disc with more than 33% obliteration of the spinal channel.
  • Annulus rupture with sequestrated herniated disc.
  • Pain on VAS below 50 mm
  • Pain existing longer than one year
  • Less than 50% preserved disc height
  • Conflict with social security/insurance.
  • Major motor impairment as a result of the herniation, paresis grade 3 or more using a Medical Research Council (MRC) score
  • Other degenerative causes of nerve root compression; ligament flavum or facet joint hypertrophy, degenerative spinal channel stenosis, loss of lumbar kyphosis, discopathy with signs of Schmorls' nodules and loss of nucleus pulposus signal. Other causes of radicular syndrome such as cancer, radiculitis or neural degeneration.
  • Spinal instability (spondylolisthesis, spinal fracture or tumor)
  • History of back surgery, chemonucleolysis or other intra discal procedures
  • Coagulopathies or oral anti-coagulation therapy
  • Infection
  • Pregnancy

Key Trial Info

Start Date :

November 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2006

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00124774

Start Date

November 1 2004

End Date

April 1 2006

Last Update

April 1 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rijnstate Hospital

Arnhem, Netherlands, 6800 TA